<DOC>
	<DOCNO>NCT00630630</DOCNO>
	<brief_summary>The relationship hormone cycling/fluctuations occurrence seizures woman receive considerable discussion medical literature . This study investigate efficacy tolerability LEV treatment subject catamenial exacerbation partial onset seizure .</brief_summary>
	<brief_title>Study Safety Efficacy Levetiracetam Adjunctive Treatment Female Subjects With C1 Catamenial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Nonpregnant nonnursing female age 18 45 year age ; outpatient epilepsy experience uncontrolled simple and/or complex partial seizure without secondary generalization minimum 2 year ; classifiable epilepsy accord International Classification Epileptic Seizures ; minimum 2 seizure per 4 week Baseline Period , without exceed 100 seizure per 4 week . The majority seizures ( &gt; 50 % ) must partial onset , without secondary generalization ; exhibit , Baseline Period , catamenial epilepsy type C1 pattern define least 70 % increase weekly seizure frequency menstrual phase compare luteal follicular phase combine ; concurrent C2 catamenial epilepsy , define 70 % increase daily seizure average ovulatory phase comparison follicular luteal phase combine , permit ; take minimum one maximum two antiepileptic drug stable dose period 4 week prior selection visit duration trial ; vagal nerve stimulator ( VNS ) permit . use felbatol present clinically significant abnormality WBCs , RBCs , platelet , and/or hepatic function felbatol treatment , take felbatol le one year date Selection Visit ; partial onset seizure uncountable due cluster last 3 month ; hormonal contraceptive block menses within 6 month selection visit washout period permit ; menstrual cycle length le 21 day great 35 day baseline evaluation ; alternative medication document purported impact reproductive hormone level , within prior 2 month washout period permit ; significantly irregular menstrual cycle history frequent amenorrhea define two episode within precede 6 month ; take hormonal contraceptive one anovulatory cycle Baseline Period ; clinically significant medical condition require treatment , except study indication , would prevent clear interpretation study result ; use follow class medication influence central nervous system : antipsychotic ( typical atypical ) , psychostimulants ( except contain methylphenidate , dextroamphetamine , amphetamine use treatment Attention Deficit Disorder ) , hypnotic ; chronically dose benzodiazepine ; hospitalize depression within 3 month prior selection visit . history attempt suicide within last 3 year , suicidal ideation within last 3 month ; recent history ( within past two year ) presence significant alcohol abuse drug abuse ; clinical history significantly impair renal function estimate creatinine clearance 80 ml/min ; history clinically significant cardiac condition ; ALT/SGPT , AST/SGOT , alkaline phosphatase , ? GT value 3 time upper limit central laboratory reference value ; presence terminal illness ; presence clinically significant allergic condition levetiracetam pyrrolidone derivative ; neutrophil count less 1800 per ? L .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
</DOC>